CVS replaces CEO Karen Lynch with exec David Joyner as profits, share price suffer
CVS has replaced CEO Karen Lynch with longtime pharmacy benefits executive David Joyner. The company has been struggling to drive higher profits and better stock performance. Last month, major CVS shareholder Glenview Capital began a significant push for changes at the company.